To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

NCT01755429 · clinicaltrials.gov ↗

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

Sponsor

Alexion Pharmaceuticals, Inc.